Oxidative DNA Damage Kit ELISA
-
- Antigène
- Oxidative DNA Damage
- Reactivité
- Others
- Méthode de détection
- Colorimetric
- Type de méthode
- Competition ELISA
- Application
- ELISA
- Fonction
- The OxiSelect™ Oxidative DNA Damage ELISA kit is a competitive ELISA for the quantitative measurement of 8-OHdG.
- Marque
- OxiSelect™
- Type d'échantillon
- Urine, Plasma, Cell Samples, Serum, Tissue Samples
- Analytical Method
- Quantitative
- Sensibilité
- 100 pg/mL
- Attributs du produit
- The OxiSelect™ Oxidative DNA Damage ELISA Kit is a competitive enzyme immunoassay developed for rapid detection and quantitation of 8-OHdG in urine, serum, or other cell or tissue DNA samples. The quantity of 8-OHdG in unknown sample is determined by comparing its absorbance with that of a known 8-OHdG standard curve. The kit has an 8-OHdG detection sensitivity range of 100 pg/mL to 20 ng/mL. Each kit provides sufficient reagents to perform up to 96 assays, including standard curve and unknown samples.
- Ingrédients
-
- 96-well Protein Binding Plate : One strip-well 96 well microplate.
- Anti-8-OHdG Antibody : One 15 μL vial of anti-8-OHdG.
- Secondary Antibody, HRP Conjugate (1000X) : One 20 μL vial.
- Assay Diluent : One 50 mL bottle.
- 10X Wash Buffer : One 100 mL bottle.
- Substrate Solution : One 12 mL amber bottle.
- Stop Solution (Part. No. 310808): One 12 mL bottle.
- 8-OHdG Standard : One 100 μL vial of 2 μg/mL 8-OHdG in 1X PBS, 0.1% BSA.
Box 2 (shipped on blue ice packs)
- Matériel non inclus
-
- 8-OHdG samples such as serum, plasma, urine, or DNA extracted from cells or tissues
- DNA Extraction Kit
- Sodium Acetate, pH 5.2
- Tris Buffer, pH 7.5
- Nuclease P1, Alkaline Phosphatase
- 10 μL to 1000 μL adjustable single channel micropipettes with disposable tips
- 50 μL to 300 μL adjustable multichannel micropipette with disposable tips
- Multichannel micropipette reservoir
- Microplate reader capable of reading at 450 nm (620 nm as optional reference wave length)
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
- Detect as little as 100 pg/mL of 8-OHdG
- Suitable for use with urine, serum, cells or tissues
- 8-OHdG standard included for absolute quantitation
- Plaque
- Uncoated
- Protocole
- The unknown 8-OHdG samples or 8-OHdG standards are first added to an 8-OHdG/BSA conjugate preabsorbed microplate. After a brief incubation, an anti-8-OHdG monoclonal antibody is added, followed by an HRP conjugated secondary antibody. The 8-OHdG content in unknown samples is determined by comparison with predetermined 8-OHdG standard curve.
- Préparation des réactifs
-
- 8-OHdG Coated Plate: Dilute the proper amount of 8-OHdG Conjugate (1 mg/mL) to 1 μg/mL in 1X PBS. Add 100 μL of the 1 μg/mL 8-OHdG Conjugate to each well and incubate 3 overnight at 4 °C. Remove the 8-OHdG coating solution and wash once with dH2O. Blot plate on paper towels to remove excess fluid. Add 200 μL of Assay Diluent to each well and block for 1 hr at room temperature. Transfer the plate to 4 °C and remove the Assay Diluent immediately before use. Note: The 8-OHdG coated wells are not stable and should be used within 24 hrs after coating. Only coat the number of wells to be used immediately.
- 1X Wash Buffer: Dilute the 10X Wash Buffer to 1X with deionized water. Stir to homogeneity.
- Anti-8-OHdG Antibody and Secondary Antibody: Immediately before use dilute the Anti-8- OHdG Antibody 1:500 and Secondary Antibody 1:1000 with Assay Diluent. Do not store diluted solutions. Preparation of Standard Curve Prepare a dilution series of 8-OHdG standards in the concentration range of 0 ng/mL to 20 ng/mL by diluting the 8-OHdG Standard in Assay Diluent (Table 1). Assay Diluent 8-OHdG Standard Tubes 8-OHdG Standard (μL) (μL) (ng/mL) 1 10 990 20 2 500 of Tube #1 500 10 3 500 of Tube #2 500 5 4 500 of Tube #3 500 2.5 5 500 of Tube #4 500 1.25 6 500 of Tube #5 500 0.625 7 500 of Tube #6 500 0.313 8 500 of Tube #7 500 0.156 9 500 of Tube #8 500 0.078 10 0 500 0 Table 1. Preparation of 8-OHdG Standards
- Préparation de l'échantillon
-
I. Urine, Plasma or Serum Samples Clear urine, plasma or serum samples can be diluted in Assay Diluent and used directly in the assay. Samples containing precipitates should be centrifuged at 3000 g for 10 minutes, or filtered through 0.45 μm filter, prior to use in the assay. Note: For mouse or rat serum or plasma samples it is highly recommended to filter the sample with a 10 kDa spin filter prior to testing. 4 II. Cell or Tissue DNA Samples
- Extract DNA from cell or tissue samples by a desired method or commercial DNA Extraction kit.
- Dissolve extracted DNA in water at 1-5 mg/mL.
- Convert DNA sample to single-stranded DNA by incubating the sample at 95 °C for 5 minutes and rapidly chilling on ice.
- Digest DNA sample to nucleosides by incubating the denatured DNA with 5-20 units of nuclease P1 for 2 hrs at 37 °C in a final concentration of 20 mM Sodium Acetate, pH 5.2, followed by treatment of 5-10 units of alkaline phosphatase for 1 hr at 37 °C in a final concentration of 100 mM Tris, pH 7.5.
- The reaction mixture is centrifuged for 5 minutes at 6000 g and the supernatant is used for the 8- OHdG ELISA assay.
- Procédure de l'essai
-
- Prepare and mix all reagents thoroughly before use. Each 8-OHdG sample including unknown and standard should be assayed in duplicate. High content 8-OHdG urine or serum samples should be diluted at least 10-20 fold in Assay Diluent.
- Add 50 μL of unknown sample or 8-OHdG standard to the wells of the 8-OHdG Conjugate coated plate. Incubate at room temperature for 10 minutes on an orbital shaker.
- Add 50 μL of the diluted anti-8-OHdG antibody to each well, incubate at room temperature for 1 hour on an orbital shaker.
- Wash microwell strips 3 times with 250 μL 1X Wash Buffer per well with thorough aspiration between each wash. After the last wash, empty wells and tap microwell strips on absorbent pad or paper towel to remove excess 1X Wash Buffer.
- Add 100 μL of the diluted Secondary Antibody-Enzyme Conjugate to all wells.
- Incubate at room temperature for 1 hour on an orbital shaker.
- Wash microwell strips 3 times according to step 4 above. Proceed immediately to the next step.
- Warm Substrate Solution to room temperature. Add 100 μL of Substrate Solution to each well, including the blank wells. Incubate at room temperature on an orbital shaker. Actual incubation time may vary from 2-30 minutes. Note: Watch plate carefully, if color changes rapidly, the reaction may need to be stopped sooner to prevent saturation. 5
- Stop the enzyme reaction by adding 100 μL of Stop Solution into each well, including the blank wells. Results should be read immediately (color will fade over time).
- Read absorbance of each microwell on a spectrophotometer using 450 nm as the primary wave length.
- Restrictions
- For Research Use only
-
- Conseil sur la manipulation
- Avoid multiple freeze/thaw cycles.
- Stock
- -20 °C/-80 °C
- Stockage commentaire
- Upon receipt, aliquot and store the 8-OHdG Standard at -20°C and the 8-OHdG Conjugate at -80°C to avoid multiple freeze/thaw cycles. Store all other components at 4°C.
-
-
Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage." dans: Biochemical and biophysical research communications, Vol. 483, Issue 1, pp. 17-23, (2017) (PubMed).
: "Nonsteroidal anti-inflammatory is more effective than anti-oxidant therapy in counteracting oxidative/nitrosative stress and heart disease in T. cruzi-infected mice." dans: Parasitology, pp. 1-13, (2017) (PubMed).
: "Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition." dans: Biochemical and biophysical research communications, Vol. 484, Issue 2, pp. 416-421, (2017) (PubMed).
: "Lung protection by inhalation of exogenous solubilized extracellular matrix." dans: PLoS ONE, Vol. 12, Issue 2, pp. e0171165, (2017) (PubMed).
: "Celastrol attenuates mitochondrial dysfunction and inflammation in palmitate-mediated insulin resistance in C3A hepatocytes." dans: European journal of pharmacology, Vol. 799, pp. 73-83, (2017) (PubMed).
: "Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival." dans: Nature communications, Vol. 8, pp. 14689, (2017) (PubMed).
: "Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II." dans: Metabolic brain disease, (2017) (PubMed).
: "Screening and Characterization of Drugs That Protect Corneal Endothelial Cells Against Unfolded Protein Response and Oxidative Stress." dans: Investigative ophthalmology & visual science, Vol. 58, Issue 2, pp. 892-900, (2017) (PubMed).
: "Mdivi-1 Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats, Possibly via Inhibition of Drp1-Activated Mitochondrial Fission and Oxidative Stress." dans: Neurochemical research, Vol. 42, Issue 5, pp. 1449-1458, (2017) (PubMed).
: "Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns." dans: PLoS ONE, Vol. 12, Issue 2, pp. e0172980, (2017) (PubMed).
: "A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway Compounds." dans: Chembiochem : a European journal of chemical biology, Vol. 16, Issue 17, pp. 2513-21, (2016) (PubMed).
: "Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice." dans: Bone marrow transplantation, (2016) (PubMed).
: "Protocatechualdehyde Protects Against Cerebral Ischemia-Reperfusion-Induced Oxidative Injury Via Protein Kinase C?/Nrf2/HO-1 Pathway." dans: Molecular neurobiology, (2016) (PubMed).
: "Diastolic Dysfunction Induced by a High-Fat Diet Is Associated with Mitochondrial Abnormality and Adenosine Triphosphate Levels in Rats." dans: Endocrinology and metabolism (Seoul, Korea), Vol. 30, Issue 4, pp. 557-68, (2016) (PubMed).
: "Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China." dans: Nutrition (Burbank, Los Angeles County, Calif.), Vol. 32, Issue 2, pp. 193-8, (2016) (PubMed).
: "Photoprotection by dietary phenolics against melanogenesis induced by UVA through Nrf2-dependent antioxidant responses." dans: Redox biology, Vol. 8, pp. 79-90, (2016) (PubMed).
: "N-acetylcysteine leads to greater ovarian protection than enoxaparin sodium in a rat ovarian torsion model." dans: Reproductive biomedicine online, (2016) (PubMed).
: "Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma." dans: Oncogene, (2016) (PubMed).
: "Restoration of Nrf2 Signaling Normalizes the Regenerative Niche." dans: Diabetes, Vol. 65, Issue 3, pp. 633-46, (2016) (PubMed).
: "αKlotho deficiency in acute kidney injury contributes to lung damage." dans: Journal of applied physiology (Bethesda, Md. : 1985), Vol. 120, Issue 7, pp. 723-32, (2016) (PubMed).
: "
-
Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage." dans: Biochemical and biophysical research communications, Vol. 483, Issue 1, pp. 17-23, (2017) (PubMed).
-
- Antigène
- Oxidative DNA Damage
- Sujet
- Free radicals and other reactive species are constantly generated in vivo and cause oxidative damage to biomolecules, a process held in check only by the existence of multiple antioxidant and repair systems as well as the replacement of damaged nucleic acids, proteins and lipids. DNA is probably the most biologically significant target of oxidative attack, and it is widely thought that continuous oxidative damage to DNA is a significant contributor to the age-related development of the major cancers, such as those of the colon, breast, rectum, and prostate. Among numerous types of oxidative DNA damage, the formation of 8-hydroxydeoxyguanosine (8-OHdG) is a ubiquitous marker of oxidative stress. 8- OHdG, one of the oxidative DNA damage byproducts, is physiologically formed and enhanced by chemical carcinogens. During the repair of damaged DNA in vivo by exonucleases, the resulting 8- OH-dG is excreted without further metabolism into urine.
-